Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Repair of complex aortic aneurysms using custom devices

Official title: Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices

Run by University of Massachusetts, Worcester · NCT02050113 · Data updated 2026-11-12

This study is testing custom-made devices to see if they can safely and effectively treat complex aortic aneurysms in patients who can't use standard options, especially those at high risk or with conditions like Marfan syndrome.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorUniversity of Massachusetts, Worcester
Academic / other
Locations1 site (Worcester, Massachusetts)
StatusRecruiting
StartedMarch 2014
Main results expectedMarch 2030
Study endsMarch 2030
Registry record updatedOctober 22, 2025
Trial IDNCT02050113 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with complex aortic aneurysms who cannot be treated with standard devices and are at high risk for open surgery.

Probably not a fit

Patients with aortic aneurysms that can be treated with currently available non-modified devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of custom-made devices and modified FDA-approved endovascular grafts for treating complex aortic aneurysms in patients whose anatomy is unsuitable for standard devices. It focuses on individuals at high risk for open surgical repair and those with connective tissue diseases like Marfan syndrome. The study involves determining the appropriate type of endograft based on patient anatomy and urgency of repair, with a third-party reviewer confirming the treatment decision. The aim is to provide a timely and effective solution for patients with critical vascular conditions.

Why it matters

Potential benefit: If successful, this approach could significantly improve treatment options and outcomes for patients with complex aortic aneurysms.

How similar studies have gone: Other studies have shown promise in using modified and custom devices for complex aortic aneurysms, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A patient may be suitable for inclusion in the study if the patient has at least one of the following:

  1. Aortic or aortoiliac aneurysm with diameter ≥5.5 cm
  2. Aortic or aortoiliac aneurysm with a history of growth ≥1.0 cm per year, or clinical indication for aneurysm repair based on symptoms

     General Inclusion Criteria

  <!-- -->

  1. Cannot be treated with a currently available non-modified approved device
  2. Symptomatic on presentation and unsafe to wait for the time necessary to obtain a currently available non-modified approved device
  3. At least 18 years of age
  4. Not pregnant or breastfeeding
  5. Willing and able to comply with five years of follow-up
  6. Willing and able to provide informed consent prior to enrollment
  7. No systemic or local infection that may increase the risk of endovascular graft infection
  8. High risk for open surgical repair based on any of the factors below:

     a. Anatomic i. Previous abdominal surgery ii. Previous left-sided thoracotomy (if the proposed open repair would require dissection of the thoracic aorta) iii. Previous aortic surgery b. Physiologic i. ASA Category III or higher ii. Age \>70 years iii. Previous myocardial infarction, coronary artery disease, or coronary artery stent iv. Coronary stress test with a reversible perfusion defect v. Congestive heart failure vi. COPD

     Exclusion Criteria:
* Exclusion Criteria Medical Exclusion Criteria

  1. Cultural objection to receipt of blood or blood products
  2. Allergy or sensitivity to stainless steel, polyester, polypropylene, solder (tin, silver), gold, or nitinol
  3. Anaphylactic reaction to contrast that cannot be adequately pre-medicated
  4. Uncorrectable coagulopathy
  5. Unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
  6. Patient has active malignancy with life expectancy of less than 2 years
  7. Patient has life expectancy less than two years

Anatomical Exclusion Criteria

1. Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access
2. Proximal neck length ≤25 mm
3. Proximal neck, measured outer wall to outer wall on a sectional image (CT)

   1. For use of Zenith Flex: diameter \>32 mm or \<18 mm
   2. For use of Zenith TX2: diameter \>38 mm or \<24 mm (for proximal and distal neck diameter)
4. Proximal neck angulated more than 60 degrees relative to the long axis of the aneurysm
5. Proximal neck diameter change over the length of the proximal seal zone \>4 mm
6. Proximal seal site with a circumferential thrombus/atheroma
7. Iliac artery diameter, measured inner wall to inner wall on a sectional image (CT) \<7.0 mm at any point along access length (prior to deployment)
8. Ipsilateral iliac artery fixation site diameter, measured inner wall on a sectional image (CT) \>21 mm at distal fixation site
9. Iliac artery distal fixation site \<10 mm in length
10. Non-bifurcated segment of any artery to be stented \< 15 mm in length
11. Artery to be stented with a maximum diameter \<3 mm or \>10 mm at the vessel ostium
12. Inability to maintain at least one patent hypogastric artery

Where it's running

  • UMass Memorial Health Care - University Campus
    Worcester, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Pregnancy-Related Aortic Dissection in China

    This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.

    Recruiting at 4 sites DeltaHealth Hospital · Shanghai · Shanghai, Shanghai Municipality and 3 other locations · NCT07672210

  • Registry for hereditary cardiovascular diseases in Brazil

    This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.

    Recruiting at 27 sites Hospital do Coracao · Rio Branco, Acre and 26 other locations · NCT06546137

  • Physician-modified endograft repair for complex abdominal and thoracoabdominal aortic aneurysms in high-risk patients

    This study will try physician-modified endografts to repair complex abdominal and thoracoabdominal aortic aneurysms in patients who are too high-risk for open surgery and do not meet criteria for currently approved devices.

    Recruiting Baylor College of Medicine · Houston, Texas · NCT07224230

  • GORE TBE Device in Zone 0/1 for Aortic Arch Conditions

    This study tests the GORE TAG Thoracic Branch Endoprosthesis in adults with aortic arch problems in Zone 0 or 1 to see how it performs over several years in routine care.

    Recruiting at 24 sites W.L.Gore & Associates · Scottsdale, Arizona and 23 other locations · NCT07166133

  • BAO-G technique for repairing complex thoracoabdominal and abdominal aortic aneurysms

    This study will try the BAO-G endovascular technique, which uses off-the-shelf iliac branched devices to rebuild visceral branches in patients with complex thoracoabdominal or abdominal aortic aneurysms who are candidates for endovascular repair.

    Recruiting at 11 sites Peking Union Medical College Hospital · Beijing, Beijing Municipality and 10 other locations · NCT07141251

  • Arcevo LSA stent graft for repairing aortic arch dissections and aneurysms

    This trial will test whether the Arcevo LSA stent graft can safely and effectively repair aortic arch and descending thoracic aortic dissections or aneurysms in adults.

    Recruiting at 26 sites Artivion Inc. · Birmingham, Alabama and 25 other locations · NCT07089576

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.